BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 25600280)

  • 1. Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
    Mathew MP; Tan E; Saeui CT; Bovonratwet P; Liu L; Bhattacharya R; Yarema KJ
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1223-7. PubMed ID: 25690786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer.
    Péron J; Roy P; Ding K; Parulekar WR; Roche L; Buyse M
    Br J Cancer; 2015 Mar; 112(6):971-6. PubMed ID: 25688740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer.
    Zhao X; Li F; Li Y; Wang H; Ren H; Chen J; Nie G; Hao J
    Biomaterials; 2015 Apr; 46():13-25. PubMed ID: 25678112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
    Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
    Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does endoscopic ultrasound-guided biliary drainage really have clinical impact?
    Ogura T; Higuchi K
    World J Gastroenterol; 2015 Jan; 21(4):1049-52. PubMed ID: 25632176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound-guided biliary drainage as an alternative to percutaneous drainage and surgical bypass.
    Prachayakul V; Aswakul P
    World J Gastrointest Endosc; 2015 Jan; 7(1):37-44. PubMed ID: 25610532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large solid-pseudopapillary neoplasm of the pancreas with aberrant protein expression and mutation of β-catenin: a case report and literature review of the distribution of β-catenin mutation.
    Kobayashi T; Ozasa M; Miyashita K; Saga A; Miwa K; Saito M; Morioka M; Takeuchi M; Takenouchi N; Yabiku T; Kanno H; Yuzawa S; Tanino M; Tanaka S; Kawakami H; Asaka M; Sakamoto N
    Intern Med; 2013; 52(18):2051-6. PubMed ID: 24042511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
    Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
    Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonductal Pancreatic Cancers.
    Jun SY; Hong SM
    Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
    Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
    Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
    Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
    JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin-negative acinar cell carcinoma of the pancreas: report of a case showing a solid pseudopapillary growth pattern.
    Tajima S; Waki M; Azuma M; Koda K; Ohata A
    Med Mol Morphol; 2016 Sep; 49(3):177-81. PubMed ID: 25600280
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.